Skip to main content
Erschienen in: Journal of Radiation Oncology 4/2012

01.12.2012 | Review

A review on the technical and dosimetric aspects of stereotactic body radiation therapy (SBRT)

verfasst von: Cheng B Saw, Shanglian Bao, Sicong Li

Erschienen in: Journal of Radiation Oncology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy is currently enjoying much popularity due to its favorable outcomes. This treatment option had been derived from stereotactic radiosurgery (SRS) which uses focus irradiation technique to deliver a very high dose to a small intracranial target. The focus irradiation technique is performed using multiple collimated beams directed at the target from around the patient. Advancement in technology has provided similar tools on tomotherapy, modern medical linear accelerators, and dedicated system such as the Cyberknife to perform SBRT. Such tools include immobilization systems, 3D treatment planning systems, image-guidance system for precise localization, and accurate dose delivery systems. Each of these systems is being briefly reviewed. While the technical specifications of the equipment for SBRT are favorable, the dosimetric aspects need attention when performing treatment planning and managing target/organ motion. Because of the delivery of high doses in one or few fractions, special considerations must be given to transient doses through neighboring structures to avoid or reduce radiation toxicities for SBRT. Like SRS, direct involvement of medical physicists is essential for both the quality assurance and clinical procedures.
Literatur
1.
Zurück zum Zitat Potters L, Kavanagh B, Galvin JM et al (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326–332PubMedCrossRef Potters L, Kavanagh B, Galvin JM et al (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326–332PubMedCrossRef
3.
Zurück zum Zitat Tipton K, Launders JH, Inamder R et al (2011) Stereotactic body radiation therapy: scope of the literature. Ann Intern Med 154:737–745PubMed Tipton K, Launders JH, Inamder R et al (2011) Stereotactic body radiation therapy: scope of the literature. Ann Intern Med 154:737–745PubMed
4.
Zurück zum Zitat Martin A, Gaya A (2010) Stereotactic body radiotherapy: a review. Clin Oncol 22:157–172CrossRef Martin A, Gaya A (2010) Stereotactic body radiotherapy: a review. Clin Oncol 22:157–172CrossRef
5.
Zurück zum Zitat Leksell LT (1951) The stereotactic method and radiosurgery of the brain. Acta Chir Scand 102:316PubMed Leksell LT (1951) The stereotactic method and radiosurgery of the brain. Acta Chir Scand 102:316PubMed
6.
Zurück zum Zitat AAPM (1995) AAPM report no. 54. Stereotactic radiosurgery. AIP, Woodbury, NY AAPM (1995) AAPM report no. 54. Stereotactic radiosurgery. AIP, Woodbury, NY
7.
Zurück zum Zitat Diot Q, Kavanagh S, Timmerman R et al (2012) Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med Phy 39:237–245CrossRef Diot Q, Kavanagh S, Timmerman R et al (2012) Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med Phy 39:237–245CrossRef
8.
Zurück zum Zitat Saw CB, Chen H, Beatty RE et al (2008) Multimodality image fusion and planning and dose delivery for radiation therapy. Med Dosm 33:149–155CrossRef Saw CB, Chen H, Beatty RE et al (2008) Multimodality image fusion and planning and dose delivery for radiation therapy. Med Dosm 33:149–155CrossRef
9.
Zurück zum Zitat Lax I, Blomgren H, Naslund I et al (1994) Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncol 33:677–683PubMedCrossRef Lax I, Blomgren H, Naslund I et al (1994) Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncol 33:677–683PubMedCrossRef
11.
Zurück zum Zitat Hoppe BS, Laser BL, Kowalski AV et al (2008) Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys 72:1283–1286PubMedCrossRef Hoppe BS, Laser BL, Kowalski AV et al (2008) Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys 72:1283–1286PubMedCrossRef
16.
Zurück zum Zitat Linda A, Trovo M, Bradley JD (2011) Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eu J Radiol 79:147–154CrossRef Linda A, Trovo M, Bradley JD (2011) Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eu J Radiol 79:147–154CrossRef
23.
Zurück zum Zitat Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of the AAPM Task Group 101. Med Phys 37:4078–4101PubMedCrossRef Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of the AAPM Task Group 101. Med Phys 37:4078–4101PubMedCrossRef
24.
Zurück zum Zitat Solberg TD, Balter JM, Benedict SH et al (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pro 2:2–9 Solberg TD, Balter JM, Benedict SH et al (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pro 2:2–9
Metadaten
Titel
A review on the technical and dosimetric aspects of stereotactic body radiation therapy (SBRT)
verfasst von
Cheng B Saw
Shanglian Bao
Sicong Li
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Radiation Oncology / Ausgabe 4/2012
Print ISSN: 1948-7894
Elektronische ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-012-0025-z

Weitere Artikel der Ausgabe 4/2012

Journal of Radiation Oncology 4/2012 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.